Vickers Venture Partners

San Francisco, California
Firm Location:San Francisco, California • Palo Alto, California
Investor Firms That Co-Invest with Vickers Venture Partners
Vickers Venture Partners Team
Photo of Xinhong Lim, Managing Director at Vickers Venture Partners
Xinhong Lim
Vickers Venture Partners·Managing Director
Sweet spot: $5.0M
Range: $3.0M - $10.0M
Investors in Singapore, Investors in United Kingdom, Investors in United States, Investors in China, Investors in Indonesia, Investors in Canada
Investors in AI (Series B), Investors in ClimateTech/CleanTech (Series B), Investors in BioTech (Series B), Investors in EnergyTech (Series B), Investors in ClimateTech/CleanTech (Series A), Investors in EnergyTech (Series A), Investors in Medical Devices (Series B), Investors in Medical Devices (Series A), Investors in Material Science (Series B), Investors in Pharmaceuticals (Series B), Investors in Material Science (Series A), Investors in Chemicals (Series A), Investors in Chemicals (Series B), Investors in BioTech (Series A), Investors in Semiconductors (Series A), Investors in Semiconductors (Series B), Investors in Pharmaceuticals (Series A), Investors in Diverse Investors (Other Lists), Investors in AI (Series A), Investors in Investors who invested in female founders (Other Lists), Investors in Investors who invested in diverse founders (Other Lists), Investors in AI (Series A), Investors in BioTech (Series A), Investors in San Francisco Bay Area (Other Lists), Investors in ClimateTech/CleanTech (Series A), Investors in EnergyTech (Series A), Investors in Medical Devices (Series A), Investors in Semiconductors (Series A), Investors in Pharmaceuticals (Series A), Investors in Chemicals (Series A), Investors in AI (Series B), Investors in Material Science (Series A), Investors in BioTech (Series B), Investors in ClimateTech/CleanTech (Series B), Investors in EnergyTech (Series B), Investors in Medical Devices (Series B), Investors in Pharmaceuticals (Series B), Investors in Material Science (Series B), Investors in Semiconductors (Series B), Investors in Chemicals (Series B), Investors in Canada (Other Lists), Investors in Therapeutics (Series A), Investors in Therapeutics (Series A), Investors in Therapeutics (Series B), Investors in Therapeutics (Series B)